Table 1. Baseline characteristics of mothers and babies allocated to each dosage group.
| Single Dose | Multiple Dose | |||||||
|---|---|---|---|---|---|---|---|---|
| Placebo | Dextrose 0.5 ml/kg | Dextrose 1 ml/kg | Placebo | Dextrose 0.5 ml/kg x 4 | Dextrose 1 ml/kg x 1, 0.5 ml/kg x 3 | Any Dose of Placebo Gel | Any Dose of Dextrose Gel | |
| Mothers (n = 403 * ) | ||||||||
| Number | 70 | 66 | 71 | 68 | 68 | 70 | 138 | 275 |
| Maternal Age (y) | 33 (5) | 33 (5) | 33 (5) | 32 (6) | 32 (5) | 32 (5) | 32 (6) | 32 (5) |
| Parity | 2 (1–8) | 2 (0–7) | 1 (1–5) | 2 (0–5) | 2 (1–10) | 2 (1–8) | 2 (0–8) | 2 (0–10) |
| Weight at Booking (kg) | 77 (23) | 79 (23) | 76 (23) | 74 (21) | 75 (24) | 77 (26) | 76 (22) | 77 (24) |
| Diabetic | 51 (73) | 49 (74) | 51 (72) | 49 (72) | 51 (75) | 50 (71) | 100 (72) | 201 (73) |
| Type 1 Diabetes | 5 (10) | 3 (6) | 2 (4) | 2 (4) | 3 (6) | 3 (6) | 7 (7) | 11 (5) |
| Type 2 Diabetes | 4 (8) | 3 (6) | 7 (14) | 3 (6) | 4 (8) | 4 (8) | 7 (7) | 18 (9) |
| Gestational Diabetes | 42 (82) | 43 (88) | 42 (82) | 44 (90) | 44 (86) | 43 (86) | 86 (86) | 172 (86) |
| Insulin Therapy | 37 (73) | 33 (67) | 37 (73) | 36 (73) | 40 (78) | 31 (62) | 73 (73) | 141 (70) |
| Pre-eclampsia | 4 (6) | 3 (5) | 1 (1) | 2 (3) | 1 (1) | 4 (6) | 6 (4) | 9 (3) |
| Hypertension | 3 (4) | 6 (9) | 8 (11) | 7 (10) | 4 (6) | 14 (20) | 10 (7) | 32 (12) |
| Prioritised Ethnicity | ||||||||
| Māori | 9 (13) | 6 (9) | 5 (7) | 10 (15) | 8 (12) | 4 (6) | 9 (14) | 23 (8) |
| Pacific | 9 (13) | 13 (20) | 12 (17) | 11 (16) | 9 (13) | 13 (19) | 20 (14) | 47 (17) |
| Chinese | 5 (7) | 7 (11) | 8 (11) | 10 (15) | 8 (12) | 6 (9) | 1 (11) | 29 (11) |
| Indian | 12 (17) | 6 (9) | 9 (13) | 13 (19) | 15 (22) | 7 (10) | 25 (18) | 37 (13) |
| Other | 15 (21) | 19 (29) | 11 (15) | 15 (22) | 10 (15) | 14 (20) | 30 (22) | 54 (20) |
| NZ European | 20 (29) | 15 (23) | 26 (37) | 9 (13) | 18 (26) | 26 (37) | 29 (21) | 85 (31) |
| Babies (n = 415) | ||||||||
| Number | 70 | 66 | 73 | 68 | 68 | 70 | 138 | 277 |
| Female | 30 (43) | 36 (55) | 42 (58) | 33 (49) | 34 (50) | 27 (39) | 63 (46) | 139 (50) |
| Birthweight (g) | 3,210 (653) | 3,265 (627) | 3,251 (611) | 3,288 (613) | 3,231 (580) | 3,229 (621) | 3,248 (633) | 3,244 (607) |
| Birthweight Z Score | 0.07 (1.33) | 0.28 (1.30) | 0.20 (1.31) | 0.18 (1.32) | 0.09 (1.32) | 0.03 (1.20) | 0 (1) | 0 (1) |
| Gestation (wk) | 38 (1) | 38 (1) | 38 (1) | 38 (1) | 38 (1) | 38 (1) | 38 (1) | 38 (1) |
| Singleton Birth | 65 (93) | 61 (92) | 65 (89) | 63 (93) | 65 (97) | 65 (93) | 128 (93) | 256 (92) |
| Caesarean Birth | 36 (51) | 35 (53) | 33 (45) | 36 (53) | 27 (40) | 32 (46) | 72 (52) | 127 (46) |
| Apgar Score of <5 at 5 min | 2 (3) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (1) | 0 (0) |
| Primary Risk Factor for Hypoglycaemia | ||||||||
| Infant of Mother with Diabetes | 51 (73) | 49 (74) | 51 (70) | 49 (72) | 51 (75) | 50 (71) | 100 (72) | 201 (73) |
| Late Preterm | 3 (4) | 5 (8) | 7 (10) | 3 (4) | 3 (4) | 6 (9) | 6 (4) | 21 (8) |
| Small | 10 (14) | 7 (11) | 8 (11) | 8 (12) | 7 (10) | 9 (13) | 18 (13) | 31 (11) |
| Large | 6 (9) | 5 (8) | 7 (10) | 8 (12) | 7 (10) | 5 (7) | 14 (10) | 24 (9) |
| Babies with Two Risk Factors | 7 (21) | 3 (8) | 10 (14) | 17 (26) | 9 (12) | 2 (6) | 4 (6) | 6 (9) |
| Babies with Three Risk Factors | 0 (0) | 1 (3) | 1 (1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Data are n (%), mean (standard deviation [SD]), or median (range).
* There are 12 mothers of twins, of whom 10 appear in more than one column because each twin was assigned to a different treatment group.